Elan Shares Rise on Report Biogen May Bid More Than $10 Billion
480434
Shares of Elan Corp., Ireland&#39;s biggest drugmaker, rose as much as 7.7 percent after a newspaper reported that the company&#39;s US partner Biogen Idec Inc.
498346
Vanda Pharmaceuticals, which went public in April at $10 a share, has seen that price soar to more than $26 in the past month after reporting positive late-stage test results for two of its drugs.
633763
Stocks rose sharply on Tuesday as talk that aluminum maker Alcoa Inc.  may be a takeover target bolstered optimism over deals and as energy shares gained with a rebound in oil prices.
747572
TORONTO - Biomira Inc. shares rocketed up more than 118 per cent on Friday on some positive results for a lung cancer vaccine the company is developing with Germany&#39;s Merck.
128490
Diversified manufacturer General Electric Co. (GE) said on Friday it boosted its quarterly dividend by 10 percent and earmarked up to $15 billion for share repurchases over the next three years.
316242
Shares of Quest Diagnostics Inc. jumped more than 10 percent and its options volume turned busy Thursday afternoon amid renewed speculation that it is a takeover target.
189520
Shares of Mylan Laboratories Inc., the largest US maker of generic drugs, surged Thursday after the company said investor Carl Icahn was given the green light by regulators to buy up to $500 million of the company&#39;s stock.
748684
Shares of Biomira Inc., a Canadian drug developer, jumped 94 percent and Merck KGaA, Germany&#39;s fourth-largest drugmaker, rose as much as 6.4 percent after the companies said data from
278048
TORONTO - Shares of flu vaccine maker ID Biomedical surged more than 10 per cent Monday after it announced US distribution deals that could bring $2.3 billion US in revenue for the company.
457592
Shares in British insurer Resolution  climbed more than 3 percent in early trade on Monday on hopes of a 5 billion pound ($10.2 billion) bid from rival Standard Life , backed by Swiss Re .
13478
Blue-chip stocks rose on Friday, lifting the Dow to a record, as General Electric Co  increased a stock buyback plan and a report showed consumer sentiment rose in early July.
728219
SHARES in Biota Holdings surged 27 per cent yesterday after the Melbourne biotech company secured rare US government funding of $US5.
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
665690
The developing biopharmaceutical company announces a share offering.
40523
CHARLOTTE, N.C. -- Shares of Barclays PLC rose more than 4 percent yesterday after an investment analyst advised clients that Bank of America Corp. may be interested in bidding for the London-based banking company.
142092
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in after-hours trading Tuesday after Tysabri, a drug used for the treatment of multiple sclerosis, was approved by the US Food and Drug Administration.
16443
Biogen and Elan receive an additional approval for Tysabri.